Citigroup’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $86.6K | Sell |
|
|||||
|
2025
Q2 | $656K | Sell |
|
|||||
|
2025
Q1 | $1.2M | Sell |
|
|||||
|
2024
Q4 | $1.06M | Buy |
|
|||||
|
2024
Q3 | $540K | Buy |
|
|||||
|
2024
Q2 | $225K | Sell |
|
|||||
|
2024
Q1 | $996K | Buy |
|
|||||
|
2023
Q4 | $28.7K | Buy |
|
|||||
|
2023
Q3 | $6.68K | Sell |
|
|||||
|
2023
Q2 | $134K | Sell |
|
|||||
|
2023
Q1 | $348K | Sell |
|
|||||
|
2022
Q4 | $810K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2021
Q3 | $25K | Buy |
|
|||||
|
2021
Q2 | $31K | Buy |
|
|||||
|
2021
Q1 | $37K | Sell |
|
|||||
|
2020
Q4 | $699K | Buy |
|